Skip to main content
. 2025 Mar 24;14(5):989–1003. doi: 10.1007/s40123-025-01130-1

Table 2.

Demographics and baseline ocular characteristics

Characteristic Overall (N = 210)
Age (years)
 Mean ± standard deviation 62.3 ± 11.66
 Minimum, maximum 24, 85
Age category, n (%)
 18 to < 65 years 103 (49.0)
  ≥ 65 years 107 (51.0)
Sex, n (%)
 Male 109 (51.9)
 Female 101 (48.1)
Race, n (%)
 White 210 (100)
Ethnicity, n (%)
 Hispanic or Latino 0
 Not Hispanic or Latino 210 (100)
Eye color, n (%)
 Blue 7 (3.3)
 Brown 166 (79.0)
 Green 6 (2.9)
 Hazel 31 (14.8)
 Other 0
Type of disease, n (%)
 Open-angle glaucoma 210 (100)
 Ocular hypertension 0
Number of IOP-lowering medication classes, n (%)
 0 101 (48.1)
 1 48 (22.9)
 2 46 (21.9)
 3 15 (7.1)
IOP-lowering medication classes, n (%)
 Alpha agonist 18 (8.6)
 Beta blocker 80 (38.1)
 Carbonic anhydrase inhibitor 59 (28.1)
 Prostaglandin analog 28 (13.3)
 Rho kinase inhibitor 0
 Miotic 0
Intraocular pressure (mmHg)
 Mean ± standard deviation 19.74 ± 4.405
Vertical cup-to-disc ratio
 Mean ± standard deviation 0.68 ± 0.092
Corneal thickness (µm)
 Mean ± standard deviation 539.8 ± 33.99
Shaffer angle grade, n (%)
 III 55 (26.2)
 IV 155 (73.8)

IOP Intraocular pressure